Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Peter Kunach(Montreal Neurological Institute and Hospital), Sarah H. Shahmoradian(Southwestern Medical Center), Brian K. Shoichet(University of California, San Francisco), Joseph Therriault(Douglas Mental Health University Institute), Marc I. Diamond(Southwestern Medical Center), Jaime Vaquer‐Alicea(Southwestern Medical Center), Gassan Massarweh(McGill University), Jean‐Paul Soucy(Montreal Neurological Institute and Hospital), Matthew S. Smith(University of California, San Francisco), Nesrine Rahmouni(McGill University), Cécile Tissot(Hirslanden Clinique des Grangettes), Robert Hopewell(Montreal Neurological Institute and Hospital), Pedro Rosa‐Neto(Montreal Neurological Institute and Hospital), Jim Monistrol(Institute for Neurodegenerative Disorders), Marie‐Christine Guiot(McGill University), Luc Moquin(Montreal Neurological Institute and Hospital)
Cited by 24
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
A practical guide to large-scale docking
|Nature Protocols|2021|540